Please login to the form below

Not currently logged in
Email:
Password:

UK Dementia Research Institute

This page shows the latest UK Dementia Research Institute news and features for those working in and with pharma, biotech and healthcare.

Latest Intelligence

  • Holding on to hope for Alzheimer’s advances Holding on to hope for Alzheimer’s advances

    So 2017 begins and hopes rise again, not least with the creation in the UK of its new Dementia Research Institute. ... The project is a joint £250m investment into dementia research led by the Medical Research Council, alongside the Alzheimer’s

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • UK Dementia Research Institute names director UK Dementia Research Institute names director

    UK Dementia Research Institute names director. Prof Bart De Strooper to lead the national institute. ... Prof Bart De Strooper has been appointed as director of the UK Dementia Research Institute, and will lead the venture from University College London.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics